MWIV Key Stats
| Income Statement | |
| Revenue TTM | 2.242B |
| Revenue Quarterly YoY Growth | 11.03% |
| EPS Diluted TTM | 4.654 |
| EPS Diluted Quarterly YoY Growth | 14.42% |
| Net Income TTM | 58.95M |
| Profitability | |
| Gross Profit Margin Quarterly | 13.26% |
| Profit Margin Quarterly | 2.68% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 1.544B |
| Enterprise Value | 1.568B |
| PE Ratio TTM | 25.91 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 1.153 |
| Price / Book Value | 3.953 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.1638 |
| Free Cash Flow | -11.92M |
| Return on Equity | 16.38% |
MWIV News
- Are MWI Veterinary Supply's Earnings Worse Than They Look? May 14
- MWIV, BECN, AVT And LKQ, Pushing Wholesale Industry Downward May 7
- Got Growth? These 5 Stocks Do May 7
- MWI Vet Earnings Beat, Sales Miss May 3
- MWI Vet Earnings Beat, Sales Miss - Analyst Blog Zacks May 3
- MWI Veterinary Supply's CEO Hosts F2Q2013 Results - Earnings Call Transcript Seeking Alpha May 2
- Becton Beats Earnings, Guides High May 2
- Becton Beats Earnings, Guides High - Analyst Blog Zacks May 2
- MWI Veterinary Supply, Inc. (MWIV) Tops Q2 EPS by 2c; Boosts FY13 Outlook Street Insider May 2
- MWI Veterinary Supply Earnings: Everything You Must Know Now May 2
MWIV Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MWI Veterinary Supply is up 33.00% over the last year vs S&P 500 Total Return up 31.95%, Henry Schein up 31.74%, and Patterson Companies up 23.42%.
MWIV Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these MWIV related companies
Pro Ratings for MWIV
Pro Report PDF for MWIV
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download MWIV Pro Report PDF
Pro Strategies Featuring MWIV
Did MWI Veterinary Supply make it into our Pro Portfolio Strategies?
MWIV Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical Distribution
MWI Veterinary Supply, Inc. is engaged in the distribution of animal health products to veterinarians. It offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food and nutritional products. The company's pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics and hormones vaccine products. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia and parvovirus. Its capital equipment includes anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cages, lights and x-ray machines. The company's veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews and specialty treats. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. The company was founded by Millard Wallace Ickes in 1976 and is headquartered in Boise, Idaho.
Other MWIV Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MWIV | 120.58 | +3.08 | +2.62% | 1.544B |
